05/01/2024
3:31 PM | Alzamend Neuro (Filer)
| Form DEFA14A | |
04/23/2024
7:00 PM | Alzamend Neuro (Issuer)
AULT MILTON C III (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
04/03/2024
4:00 PM | Alzamend Neuro (Issuer)
AULT MILTON C III (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
04/01/2024
3:30 PM | Alzamend Neuro (Issuer)
AULT MILTON C III (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/29/2024
3:30 PM | Alzamend Neuro (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
03/28/2024
3:30 PM | Alzamend Neuro (Issuer)
AULT MILTON C III (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/25/2024
4:27 PM | Alzamend Neuro (Filer)
| Form 10-Q
General form for quarterly reports under Section 13 or 15(d) | |
|
03/22/2024
3:30 PM | Alzamend Neuro (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
03/18/2024
3:30 PM | Alzamend Neuro (Filer)
| Form NT 10-Q | |
03/13/2024
3:30 PM | Alzamend Neuro (Filer)
| Form PRE 14A | |
03/07/2024
3:30 PM | Alzamend Neuro (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
02/02/2024
3:38 PM | Alzamend Neuro (Subject)
AULT MILTON C III (Filed by)
| Form SC 13D/A | |
02/02/2024
3:30 PM | Alzamend Neuro (Issuer)
AULT MILTON C III (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/02/2024
3:30 PM | Alzamend Neuro (Filer)
Alzamend Neuro (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
01/25/2024
4:20 PM | Alzamend Neuro (Issuer)
AULT MILTON C III (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
01/25/2024
4:21 PM | Alzamend Neuro (Subject)
AULT MILTON C III (Filed by)
| Form SC 13D/A | |
01/09/2024
3:30 PM | Alzamend Neuro (Issuer)
AULT MILTON C III (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
01/05/2024
3:30 PM | Alzamend Neuro (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
12/27/2023
3:30 PM | Alzamend Neuro (Issuer)
AULT MILTON C III (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
12/15/2023
3:30 PM | Alzamend Neuro (Filer)
| Form 10-Q
General form for quarterly reports under Section 13 or 15(d) | |
11/16/2023
3:30 PM | Alzamend Neuro (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
10/30/2023
3:30 PM | Alzamend Neuro (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
09/26/2023
5:01 PM | Alzamend Neuro (Issuer)
Katzoff David J (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
09/22/2023
3:30 PM | Alzamend Neuro (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
09/13/2023
4:09 PM | Alzamend Neuro (Filer)
| Form 10-Q
General form for quarterly reports under Section 13 or 15(d) | |
09/08/2023
4:05 PM | Alzamend Neuro (Filer)
| Form 424B5 | |
09/01/2023
3:30 PM | Alzamend Neuro (Filer)
| Form DEFA14A | |
08/24/2023
3:30 PM | Alzamend Neuro (Filer)
| Form DEF 14A | |
08/16/2023
3:30 PM | Alzamend Neuro (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
08/10/2023
11:15 PM | Alzamend Neuro (Filer)
| Form EFFECT | |
06/22/2023
3:30 PM | Alzamend Neuro (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
05/26/2023
8:30 PM | Alzamend Neuro (Issuer)
AULT MILTON C III (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
